IP Library Granted Patent US 8,454,977
Granted Patent B2
US 8,454,977 · App. 13/179,058 · Granted Jun 4, 2013

Non-toxic biofilm inhibitor

Inventors: Robert S. Hodges (Denver, CO); Randall T. Irvin (Sherwood Park, CA); Carmen Giltner (St. Albert, CA); Erin Van Schaik (Calgary, CA)
Assignee: The Regents of the University of Colorado, a Body Corporate
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,454,977
App. No.
13/179,058
Granted
Jun 4, 2013
Kind
B2
Abstract

The present invention relates to a composition, device and method for preventing or inhibiting biofilm formation on biotic or abiotic surfaces. The composition comprises a peptide based on the C-terminal receptor binding domain of Pseudomonas aeruginosa type IV pilin, which binds to an abiotic surface (e.g., steel, plastic) with high affinity and prevents binding of a variety of P. aeruginosa strains to the surface. The inventive composition represents a non-toxic inhibitor for biofilm formation, particularly on an abiotic surface, which is responsible for a large number of problematic diseases and massive economic losses. The inventive method is useful as a safe and environmentally friendly means of modifying a surface of a variety of biomedical, nanotechnological, and biotechnological devices or articles.

Claims (6)

1. A medical device having surfaces that are exposed to bacterial biofilm formation when the device is implanted in a body, in which such surfaces are coated with a synthetic pilin peptide having a core amino acid sequence of K/A/S/T-C -T/K/A-S/T-D/T/N-Q/V/A-D/E-E/P/A/N-Q/M/K-F/Y-I/T/R/L-P-K/N-G/T-C-S/D/T/Q/N-K/N/D/T (SEQ ID NO:2).

2. The device of claim 1 , wherein the synthetic pilin peptide coating the device surfaces has a core amino acid sequence selected from the group consisting of ID NOS:3, 4, 5, 6, 7, 13, 14, 15, 17, 18, and 19.

3. The device of claim 2 , wherein the synthetic pilin peptide coating the device surfaces has the core amino acid sequence of SEQ ID NO:3 or 4.

4. The device of claim 1 , wherein the coated surfaces are made of a material selected from the group consisting of stainless steel, tin, aluminum, titanium, chromium, plastic, glass, silicate, ceramics, and a mixtures thereof.

5. The device of claim 4 , wherein the coated surfaces are made of stainless steel.

6. The device of claim 4 , wherein the plastic is made of polyvinylchloride or polystyrene.

Assignments (1)
CONFIRMATORY LICENSE Recorded Oct 27, 2011
From: UNIVERSITY OF COLORADO
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 027129/0995 →
Continuity (3)
Continuation 11996379
Provisional Application 60701561 · Jul 22, 2005
Related Publication 20120016102A1 · Jan 19, 2012